Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Prostatic Neoplasms 26Breast Neoplasms 5Leiomyoma 3Neoplasms 2Sleep Wake Disorders 1Sarcopenia 1Prostatectomy 1Polycystic Ovary Syndrome 1Pelvic Pain 1Osteoporosis 1Neoplasm Metastasis 1Kallmann Syndrome 1Hypogonadism 1Hyperprolactinemia 1Highly Endocrine Responsive Operable Breast Cancer 1Hemorrhage 1Fatigue 1Endometriosis 1Cardiovascular Diseases 1Breast Neoplasms, Male 1Advanced Prostate Cancer 1Adenomyosis 1

Interventions

Tablets 1Letrozole 1Gonadotropin-Releasing Hormone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Highly Endocrine Responsive Operable Breast Cancer × Gonadotropin-Releasing Hormone × Clear all
NCT03397537 2018-01-17

Neoadjuvant Endocrine Therapy in Breast Cancer

Guangdong Provincial People's Hospital

Phase 2 Completed
46 enrolled
Breast

Highly Endocrine Responsive Operable Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡